Extracorporeal Life Support (ECLS) may provide pulmonary and circulatory support for patients with acute heart failure refractory to conventional medical therapy. However, indications and effectiveness of ECLS engagement post-surgery remains a concern. The investigators sought to analyze indications, modality and outcomes of PS-ECLS, to identify predictors of early and midterm survival after PS-ECLS. The investigators have recorded prospectively, and analysed data of 209 consecutive PS-ECLS patients between January 2004 and December 2018. Demographic and clinical data before, during and after PS-ECLS were collected and their influence on hospital mortality and outcomes (early and midterm) will analyse. Multivariate analysis of pre PS-ECLS implantation factors (as age, female sex , insulin-dependent diabetes, pulmonary hypertension, STS, type of surgical procedure data, pre-ECLS blood lactate level) will be made for identify prognostic risk factors of in-hospital mortality. Overall survival will be analysed, at 6 months,1-year and 5-years, respectively and the factors influencing mild/term outcome will be investigated.
Study Type
OBSERVATIONAL
Enrollment
500
Emergency application of Extracorporeal Life Support in post-surgical patients
Massimo Bonacchi
Florence, Italy
RECRUITINGSurvival
Evaluate Early, mid and late Survival
Time frame: 1 month after surgery
Survival
mid-time survival
Time frame: At 1 Year after surgery
Survival
late survival
Time frame: At 5 years after surgery
Prognostic factors
Identify early and late negative and positive prognostic factors
Time frame: Early: 1 month after surgery
Prognostic Factors
Identify early and late negative and positive prognostic factors
Time frame: Late: 5 years after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.